Kromoglin

Roman name

Cromoglin

The composition and the form of

Spray for the nazalnogo-15 mlkromoglikat sodium-300 mgwo bottle with a sprayer to 15 ml; In a Box 1 Flakon.kapli eye-1 mlkromoglikat sodium-20 mgwo meals to 10 ml; In a box one bottle.

Pharmacokinetics

In intra-less than 7% imposed dose absorbed from the nasal cavity in the blood system; After inhalation to 10% of the active substance comes in the lower divisions of the respiratory tract and fully rezorbiruetsa system in the bloodstream. Does not metabolised, leaving the body in an unmodified form with urine and jelchew approximately equal numbers. Part of the active substance, which is deposited in the mouth and throat, and proglatavetsa without substantial absorption is through blood.

Indications

Allergic rhinitis (prevention and treatment), the prevention of attacks of asthma (including by stress), prophylactic use in chronic bronchitis with bronhospasticski component.

Pregnancy and lactation

Valid only on the strict condition. Close medical supervision.

Contraindications

Hypersensitivity, children (up to 5 years), age (measured for intranasal spray).

Side-Effects

Irritation of nasal mucous membrane (for intranasal spray), cough, slight dryness in the throat, bronhospasticskie phenomenon.

Storage conditions

At room temperature

Shelf life

3 years

The registration

015765/01

Directory → Intermedianta → Gistaminergicakie funds → Gistaminolitiki → Stabilisers membranes fat cells → Kromoglin